MMI completes Series B financing for Symani commercialization
MMI completed Series B financing led by Deerfield Management to expand Symani commercialization and clinical development.
Evidence notes
- RA Capital Management and BioStar Capital joined the round alongside Andera Partners, Fountain Healthcare Partners, Panakès Partners and Sambatech.
- The financing supported European commercialization, U.S. and Asia-Pacific market plans, and clinical research.
- MMI retained its Pisa Center of Excellence for research, manufacturing and other operations after redomiciling to the United States.
Company overview
Surgical-robotics company developing the Symani system for microsurgery and supermicrosurgery.